# reload+after+2024-01-22 19:45:26.349630
address1§350 5th Avenue
address2§Suite 5330
city§New York
state§NY
zip§10118
country§United States
phone§646 600 6438
website§https://in8bio.com
industry§Biotechnology
sector§Healthcare
longBusinessSummary§IN8bio, Inc., a clinical-stage biopharmaceutical company, focuses on the discovery, development, and commercialization of gamma-delta T cell therapies for the treatment of cancers. Its lead product candidates include INB-200, a genetically modified autologous gamma-delta T cell product candidate that is in Phase I clinical trial for the treatment of glioblastoma and solid tumors; INB-100, an allogeneic product candidate, which is in Phase I clinical trial to treat patients with acute leukemia undergoing hematopoietic stem cell transplantation; and INB-400, which is in Phase 2 clinical trial to treat newly diagnosed GBM. It also develops INB-300, INB-410, and INB-500 that are in preclinical Phase for treatment of various solid tumor cancers. The company was formerly known as Incysus Therapeutics, Inc. and changed its name to IN8bio, Inc. in August 2020. IN8bio, Inc. was incorporated in 2016 and is headquartered in New York, New York.
fullTimeEmployees§31
companyOfficers§[{'maxAge': 1, 'name': 'Mr. Tai-Wei  Ho', 'age': 46, 'title': 'Co-Founder, President, CEO & Director', 'yearBorn': 1977, 'fiscalYear': 2022, 'totalPay': 837000, 'exercisedValue': 0, 'unexercisedValue': 0}, {'maxAge': 1, 'name': 'Dr. Kate  Rochlin Ph.D.', 'age': 42, 'title': 'Chief Operating Officer', 'yearBorn': 1981, 'fiscalYear': 2022, 'totalPay': 565400, 'exercisedValue': 0, 'unexercisedValue': 0}, {'maxAge': 1, 'name': 'Dr. Trishna  Goswami M.D.', 'age': 45, 'title': 'Chief Medical Officer', 'yearBorn': 1978, 'fiscalYear': 2022, 'totalPay': 638512, 'exercisedValue': 0, 'unexercisedValue': 0}, {'maxAge': 1, 'name': 'Dr. Lawrence S. Lamb Ph.D.', 'age': 69, 'title': 'Executive VP, Co-Founder & Chief Scientific Officer', 'yearBorn': 1954, 'fiscalYear': 2022, 'totalPay': 482473, 'exercisedValue': 0, 'unexercisedValue': 324324}, {'maxAge': 1, 'name': 'Mr. Patrick  McCall CPA', 'age': 40, 'title': 'CFO & Secretary', 'yearBorn': 1983, 'fiscalYear': 2022, 'totalPay': 519348, 'exercisedValue': 0, 'unexercisedValue': 0}]
compensationAsOfEpochDate§1672444800
maxAge§86400
priceHint§4
payoutRatio§0.0
beta§0.032
currency§USD
dateShortInterest§1702598400
forwardEps§-0.59
exchange§NGM
quoteType§EQUITY
shortName§IN8bio, Inc.
longName§IN8bio, Inc.
firstTradeDateEpochUtc§1627651800
timeZoneFullName§America/New_York
timeZoneShortName§EST
uuid§b965db48-c280-3140-b968-9f1daf98eafd
gmtOffSetMilliseconds§-18000000
targetHighPrice§14.0
targetLowPrice§8.0
targetMeanPrice§11.0
targetMedianPrice§11.0
recommendationMean§2.0
recommendationKey§buy
numberOfAnalystOpinions§2
quickRatio§2.743
grossMargins§0.0
ebitdaMargins§0.0
trailingPegRatio§None
